Complete SABS Stock Valuation Analysis
Comprehensive intrinsic value analysis using 1 different methodologies
SABS Peer Valuation Analysis
Relative valuation based on comparable company trading multiples
Peer Valuation Analysis
Fair Value Range Analysis
Based on median multiples from 8 peer companies in Healthcare
P/E Ratio
$0.00
-100.0%
Peer Median: 0.0x
EV/EBITDA
$0.00
-100.0%
Peer Median: 0.0x
P/S Ratio
$0.12
-93.8%
Peer Median: 2.9x
Interpretation: Each multiple provides a different perspective on fair value. Consider which multiple is most relevant for SABS's business model and current situation.
Multiple Comparison
| Multiple | SABS Current | Peer Median | Peer Average | Premium/Discount | Assessment |
|---|---|---|---|---|---|
| P/E Ratio | -0.5x | 0.0x | 0.0x | -Infinity% | Undervalued |
| EV/EBITDA | Infinityx | 0.0x | 0.0x | Infinity% | Overvalued |
| P/S Ratio | 46.2x | 2.9x | 5.5x | 1520.9% | Overvalued |
Peer Companies
Click any company to view their valuation
| Company | Market Cap | P/E Ratio | EV/EBITDA | P/S Ratio |
|---|---|---|---|---|
| $0.02B | 0.0x | 0.0x | 0.0x | |
| $0.02B | 0.0x | 0.0x | 2.7x | |
| $0.02B | 0.0x | 0.0x | 0.0x | |
| $0.02B | 0.0x | 0.0x | 11.0x | |
| $0.02B | 0.0x | 0.0x | 46.2x | |
| $0.02B | 0.0x | 0.0x | 2.9x | |
| $0.02B | 0.0x | 0.0x | 0.0x | |
| $0.01B | 0.0x | 0.0x | 0.0x |